Appeal No. 1997-2829
Application No. 08/456,090
the range recited in appealed claim 13. For the reasons set
forth in section VI-B3-b, supra, the dosage limitation of
baclofen recited in appealed claim 13 would have been well
within the level of skill in this art and obvious over
Kreutner. For the reasons set forth in section VI-B3-c,
supra, the Rule 132 Declaration is insufficient to show that
the dosage limitation recited in claim 13 constitutes an
unexpected result.
The rejection of claim 13 under 35 U.S.C. § 103 is
affirmed.
VII. Conclusion
In conclusion, for the reasons set forth in the body of
this opinion, we affirm the examiner’s decision rejecting
-16-
Page: Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Last modified: November 3, 2007